Stephan D. Voss, MD, PhD
Quality and Safety Physician Director, Department of Radiology; Nuclear Medicine Medical Director, Department of Radiology
Associate Professor of Radiology, Harvard Medical School
Image
Stephan D. Voss, MD, PhD
Quality and Safety Physician Director, Department of Radiology; Nuclear Medicine Medical Director, Department of Radiology
Associate Professor of Radiology, Harvard Medical School
Medical Services
Languages
English
Education
Undergraduate School
Princeton University
1984
Princeton
NJ
Medical School
University of Wisconsin
1988
Madison
WI
Internship
Beth Israel Deaconess Medical Center
1995
Boston
MA
Residency
Beth Israel Deaconess Medical Center
2000
Boston
MA
Fellowship
Pediatric Radiology
Boston Children's Hospital
2001
Boston
MA
Certifications
American Board of Radiology (Diagnostic Radiology)
American Board of Radiology (Nuclear Radiology)
American Board of Radiology (Pediatric Radiology)
Publications
Update on Surveillance in Von Hippel-Lindau Disease. View Abstract
Rasmussen encephalitis: brain MRI and 18F-FDG PET findings. View Abstract
CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL). View Abstract
Update on Whole-Body MRI Surveillance for Pediatric Cancer Predisposition Syndromes. View Abstract
Phase 1 study of NEDD8 activating enzyme inhibitor pevonedistat in combination with chemotherapy in pediatric patients with recurrent or refractory solid tumors (ADVL1615). View Abstract
Imaging Assessment of Radiation Therapy-Related Normal Tissue Injury in Children: A PENTEC Visionary Statement. View Abstract
Correction to: Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. View Abstract
Lipodystrophy in methylmalonic acidemia associated with elevated FGF21 and abnormal methylmalonylation. View Abstract
Positron emission tomography in the diagnosis and management of primary pediatric lung tumors. View Abstract
A phase 1 trial utilizing a pharmacokinetic endpoint to determine the optimal dose of ramucirumab in children and adolescents with relapsed or refractory solid tumors, including central nervous system tumors. View Abstract
Significance of E-lesions in Hodgkin lymphoma and the creation of a new consensus definition: a report from SEARCH. View Abstract
Use of intraoperative bone scintigraphy for resection of spinal osteoid osteoma. View Abstract
Reconsidering pregnancy screening policies for minors: patient-specific estimate of fetus and effective dose for potentially pregnant minors undergoing optimized dose CT of the pelvis. View Abstract
17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023. View Abstract
Yoga, aerobic and stretching exercise effects on neurocognition: Randomized controlled trial protocol. View Abstract
Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group. View Abstract
SPECT/CT, PET/CT and PET/MRI: oncologic and infectious applications and protocol considerations. View Abstract
Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy. View Abstract
Imaging of pediatric hematopoietic stem cell transplant recipients: A COG Diagnostic Imaging Committee/SPR Oncology Committee White Paper. View Abstract
Standard Adult Gastric Emptying Scintigraphy Criteria Is Applicable for Partial Meal Ingestion. View Abstract
Gamma Secretase Inhibition for a Child With Metastatic Glomus Tumor and Activated NOTCH1. View Abstract
Histologic characterization of paediatric mesenchymal neoplasms treated with kinase-targeted therapy. View Abstract
68 Ga-DOTATATE PET and functional imaging in pediatric pheochromocytoma and paraganglioma. View Abstract
Stroke after transcatheter aortic valve replacement: A severe complication with low predictability. View Abstract
Development and autoregulation of kidney function in children: a retrospective study using 99mTc-MAG3 renography. View Abstract
Belzutifan, a Potent HIF2a Inhibitor, in the Pacak-Zhuang Syndrome. View Abstract
Normative database of postural sway measures using inertial sensors in typically developing children and young adults. View Abstract
Juvenile Granulosa Cell Tumor as the Presenting Feature of McCune-Albright Syndrome. View Abstract
Response to Febo-Rodriguez et al. View Abstract
Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912). View Abstract
Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. View Abstract
Pediatric Solid Gastric Emptying Scintigraphy: Normative Value Guidelines and Nonstandard Meal Alternatives. View Abstract
Expert consensus statements for Waldeyer's ring involvement in pediatric Hodgkin lymphoma: The staging, evaluation, and response criteria harmonization (SEARCH) for childhood, adolescent, and young adult Hodgkin lymphoma (CAYAHL) group. View Abstract
Neck CT angiography examinations for pediatric oropharyngeal trauma: diagnostic yield and proposal of a new targeted technique. View Abstract
Prospective Evaluation of Radiation Dose Escalation in Patients With High-Risk Neuroblastoma and Gross Residual Disease After Surgery: A Report From the Children's Oncology Group ANBL0532 Study. View Abstract
Liver involvement in pediatric Hodgkin lymphoma: A systematic review by an international collaboration on Staging Evaluation and Response Criteria Harmonization (SEARCH) for Children, Adolescent, and Young Adult Hodgkin Lymphoma (CAYAHL). View Abstract
Normative database of spatiotemporal gait parameters using inertial sensors in typically developing children and young adults. View Abstract
Definition of cortical bone involvement in the staging of newly diagnosed pediatric Hodgkin lymphoma: A report from the International Working Group on Staging Evaluation and Response Criteria Harmonization (SEARCH). View Abstract
Phase I Clinical Trial of the Wee1 Inhibitor Adavosertib (AZD1775) with Irinotecan in Children with Relapsed Solid Tumors: A COG Phase I Consortium Report (ADVL1312). View Abstract
Functional and anatomical imaging in pediatric oncology: which is best for which tumors. View Abstract
Surveillance imaging in pediatric lymphoma. View Abstract
Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma: A Randomized Clinical Trial. View Abstract
Impact of a Two-Filter Cerebral Embolic Protection Device on the Complexity and Risk of Transcatheter Aortic Valve Replacement. View Abstract
Multicenter pre-operative assessment of pediatric ovarian malignancy. View Abstract
A Phase II Study of Alisertib in Children with Recurrent/Refractory Solid Tumors or Leukemia: Children's Oncology Group Phase I and Pilot Consortium (ADVL0921). View Abstract
Staging and following common pediatric malignancies: MRI versus CT versus functional imaging. View Abstract
Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group. View Abstract
A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group. View Abstract
Correction to: Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. View Abstract
Mid-Term Results After Sternal Reconstruction Using Titanium Plates: Is It Worth It to Plate? View Abstract
Imaging Optimization in Children. View Abstract
Ionizing radiation from computed tomography versus anesthesia for magnetic resonance imaging in infants and children: patient safety considerations. View Abstract
How we read pediatric PET/CT: indications and strategies for image acquisition, interpretation and reporting. View Abstract
Liposuction for Swelling in Patients with Lymphedema. View Abstract
Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study. View Abstract
Role of imaging in the diagnosis of parotid infantile hemangiomas. View Abstract
Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study. View Abstract
Operational and Dosimetric Aspects of Pediatric PET/CT. View Abstract
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 1. View Abstract
Cancer and Central Nervous System Tumor Surveillance in Pediatric Neurofibromatosis 2 and Related Disorders. View Abstract
Von Hippel-Lindau and Hereditary Pheochromocytoma/Paraganglioma Syndromes: Clinical Features, Genetics, and Surveillance Recommendations in Childhood. View Abstract
Pediatric Cancer Predisposition Imaging: Focus on Whole-Body MRI. View Abstract
Evaluation of the utility of 99m Tc-MDP bone scintigraphy versus MIBG scintigraphy and cross-sectional imaging for staging patients with neuroblastoma. View Abstract
Hepatocellular Carcinoma in Fanconi-Bickel Syndrome. View Abstract
Staging Evaluation and Response Criteria Harmonization (SEARCH) for Childhood, Adolescent and Young Adult Hodgkin Lymphoma (CAYAHL): Methodology statement. View Abstract
Childhood Hodgkin International Prognostic Score (CHIPS) Predicts event-free survival in Hodgkin Lymphoma: A Report from the Children's Oncology Group. View Abstract
Features and Outcome of Autonomous Thyroid Nodules in Children: 31 Consecutive Patients Seen at a Single Center. View Abstract
Post-transplant lymphoproliferative disorder of the pediatric airway: Presentation and management. View Abstract
Poor adherence to staging guidelines for children with malignant ovarian tumors. View Abstract
The ionic charge of copper-64 complexes conjugated to an engineered antibody affects biodistribution. View Abstract
Growth plate abnormalities in pediatric cancer patients undergoing phase 1 anti-angiogenic therapy: a report from the Children's Oncology Group Phase I Consortium. View Abstract
A bioorthogonal small-molecule-switch system for controlling protein function in live cells. View Abstract
Generation of an intramolecular three-color fluorescence resonance energy transfer probe by site-specific protein labeling. View Abstract
Surveillance imaging in pediatric Hodgkin Lymphoma. View Abstract
Phase 2 trial of cixutumumab in children, adolescents, and young adults with refractory solid tumors: a report from the Children's Oncology Group. View Abstract
Phase I pharmacokinetic and pharmacodynamic study of pazopanib in children with soft tissue sarcoma and other refractory solid tumors: a children's oncology group phase I consortium report. View Abstract
The radiographic appearance of split Blake drains: what you see is not necessarily what you get. View Abstract
A comparison of 2 intravenous lipid emulsions: interim analysis of a randomized controlled trial. View Abstract
Resolving bony abnormality evolves to diffuse large B-cell lymphoma. View Abstract
A low-glycemic-load versus low-fat diet in the treatment of fatty liver in obese children. View Abstract
Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study. View Abstract
Reliable estimation of incoherent motion parametric maps from diffusion-weighted MRI using fusion bootstrap moves. View Abstract
In vivo assessment of optimal b-value range for perfusion-insensitive apparent diffusion coefficient imaging. View Abstract
Surveillance computed tomography imaging and detection of relapse in intermediate- and advanced-stage pediatric Hodgkin's lymphoma: a report from the Children's Oncology Group. View Abstract
Reliable assessment of perfusivity and diffusivity from diffusion imaging of the body. View Abstract
Phase I/II trial and pharmacokinetic study of cixutumumab in pediatric patients with refractory solid tumors and Ewing sarcoma: a report from the Children's Oncology Group. View Abstract
A phase 1 study of vinblastine in combination with carboplatin for children with low-grade gliomas: a Children's Oncology Group phase 1 consortium study. View Abstract
Leukemia and lymphoma. View Abstract
Adrenal cortical tumors in children: factors associated with poor outcome. View Abstract
Pediatric oncology and the future of oncological imaging. View Abstract
Quantitative body DW-MRI biomarkers uncertainty estimation using unscented wild-bootstrap. View Abstract
Phase II study of irinotecan and temozolomide in children with relapsed or refractory neuroblastoma: a Children's Oncology Group study. View Abstract
Imaging cancer using PET--the effect of the bifunctional chelator on the biodistribution of a (64)Cu-labeled antibody. View Abstract
Antitumor activity of hu14.18-IL2 in patients with relapsed/refractory neuroblastoma: a Children's Oncology Group (COG) phase II study. View Abstract
Synovial sarcoma in children: imaging features and common benign mimics. View Abstract
Diagnostic errors in pediatric radiology. View Abstract
Primary lung tumors in children and adolescents: a 90-year experience. View Abstract
Effects of neoadjuvant chemotherapy on hepatoblastoma: a morphologic and immunohistochemical study. View Abstract
In utero diagnosis of congenital pyloric atresia in a single twin using MRI and ultrasound. View Abstract
The ALARA concept in pediatric oncology. View Abstract
Clinical course and outcome in children with acute lymphoblastic leukemia and asparaginase-associated pancreatitis. View Abstract
Irinotecan plus temozolomide in children with recurrent or refractory neuroblastoma: A phase II Children's Oncology Group study. View Abstract
Pediatric phase I and pharmacokinetic study of erlotinib followed by the combination of erlotinib and temozolomide: a Children's Oncology Group Phase I Consortium Study. View Abstract
A paradoxical signal intensity increase in fatty livers using opposed-phase gradient echo imaging with fat-suppression pulses. View Abstract
Prenatal diagnosis and subsequent treatment of an intermediate-risk paraspinal neuroblastoma: case report and review of the literature. View Abstract
Positron emission tomography (PET) imaging of neuroblastoma and melanoma with 64Cu-SarAr immunoconjugates. View Abstract
Mucoepidermoid carcinoma of bronchus in a pediatric patient: (18)F-FDG PET findings. View Abstract
3D multidetector CT angiographic evaluation of extralobar pulmonary sequestration with anomalous venous drainage into the left internal mammary vein in a paediatric patient. View Abstract
The ischiopubic synchondrosis: changing appearance on PET/CT as a mimic of disease. View Abstract
On the strong field dependence and nonlinear response to gadolinium contrast agent of proton transverse relaxation rates in dairy cream. View Abstract
Thymoma in a child: case report and review of the literature. View Abstract
Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. View Abstract
Right ventricular pseudoaneurysm after modified Norwood procedure. View Abstract
An integrated vector system for cellular studies of phage display-derived peptides. View Abstract
Solitary osteosclerotic plasmacytoma: association with demyelinating polyneuropathy and amyloid deposition. View Abstract
Chronic inflammatory pseudotumor arising in the hepatobiliary-pancreatic system: progressive multisystemic organ involvement in four patients. View Abstract
Gene therapy: a primer for radiologists. View Abstract
Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. View Abstract
Participation of the CD94 receptor complex in costimulation of human natural killer cells. View Abstract
CD94 ligation induces apoptosis in a subset of IL-2-stimulated NK cells. View Abstract
Costimulation of human natural killer cell proliferation: role of accessory cytokines and cell contact-dependent signals. View Abstract
Distinction between gamma c detection and function in YT lymphoid cells and in the granulocyte-macrophage colony-stimulating factor-responsive human myeloid cell line, Tf-1. View Abstract
X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis. View Abstract
Addendum to SCID, interleukin-2, and the interleukin-2 receptor review. View Abstract
Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way. View Abstract
Identification of a direct interaction between interleukin 2 and the p64 interleukin 2 receptor gamma chain. View Abstract
Human peripheral gamma delta T cells recognize hsp60 molecules on Daudi Burkitt's lymphoma cells. View Abstract
Characterization of the interleukin 2 receptors (IL-2R) expressed on human natural killer cells activated in vivo by IL-2: association of the p64 IL-2R gamma chain with the IL-2R beta chain in functional intermediate-affinity IL-2R. View Abstract
Serum CD25 levels during interleukin-2 therapy: dose dependence and correlations with clinical toxicity and lymphocyte surface sCD25 expression. View Abstract
Clinical and biologic effects of combination therapy with gamma-interferon and tumor necrosis factor. View Abstract
Increased expression of the interleukin 2 (IL-2) receptor beta chain (p70) on CD56+ natural killer cells after in vivo IL-2 therapy: p70 expression does not alone predict the level of intermediate affinity IL-2 binding. View Abstract
Natural killer cells activated by interleukin 2 treatment in vivo respond to interleukin 2 primarily through the p75 receptor and maintain the p55 (TAC) negative phenotype. View Abstract
The clinical immunobiology of interleukin-2: potential modified uses for improved cancer treatment. View Abstract
Serum levels of the low-affinity interleukin-2 receptor molecule (TAC) during IL-2 therapy reflect systemic lymphoid mass activation. View Abstract